
Atcas Pharmaceutical Private Limited
About Atcas Pharmaceutical Private Limited
Data last updated:
Atcas Pharmaceutical Private Limited was a private limited company based in Kolkata, West Bengal, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 November 2016.
The company was registered with the Registrar of Companies (ROC), Kolkata, under CIN U74999WB2016PTC218310. Its GSTIN is 19AAPCA2879R1ZI (West Bengal).
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It was led by directors including Subhra Das and Aftabuddin Shaikhmahammad Sircar.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Shantinikatan Apartment Gr. Floor Phase I Block C, Kolkata, West Bengal, India – 700135.
Company details
Contact details
Atcas Pharmaceutical Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShantinikatan Apartment Gr. Floor Phase I Block C, Kolkata, West Bengal, India – 700135
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Atcas Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Atcas Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Atcas Pharmaceutical Private Limited
FY 2018 filings availableFinancial Statement Summary
| Metrics | FY 2016-17 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2016-17 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Atcas Pharmaceutical Private Limited, buy the company report.
Board of directors of Atcas Pharmaceutical Private Limited
Atcas Pharmaceutical has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subhra Das Also directs: Apex Hospitex and Neuroscience Private Limited | Director | 16 Nov 2016 | 9 Years 11 Months | As last reported |
| Aftabuddin Shaikhmahammad Sircar | Director | 16 Nov 2016 | 9 Years 11 Months | As last reported |
| Amitabha Chaudhuri | Director | 16 Nov 2016 | 9 Years 11 Months | As last reported |
| Chandan Singha Roy Also directs: Macvally Pharma Private Limited | Director | 16 Nov 2016 | 9 Years 11 Months | As last reported |
Auditor
Atcas Pharmaceutical Private Limited is audited by MUNSHIAND BHATTACHARYA for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MUNSHIAND BHATTACHARYA | FY 2017 | 309141E |
Shareholding
The shareholding of Atcas Pharmaceutical Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Atcas Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Atcas Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Atcas Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Atcas Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAPCA2879R1ZI | West Bengal | Active | 10 Jan 2018 |
To see the full GST registrations and return filing status of Atcas Pharmaceutical Private Limited, buy the company report.
Recent activity
Atcas Pharmaceutical Private Limited has 5 board changes on record since 2016: 4 appointments and 1 cessation. The latest: Tanmoy Kumar Das ceased to be Director on 07 Sep 2018.
Frequently asked questions
Atcas Pharmaceutical has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Atcas Pharmaceutical was a private limited company based in Kolkata, West Bengal, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 November 2016 and is registered under CIN U74999WB2016PTC218310. The company has been struck off by the Registrar of Companies and is no longer operational.
Atcas Pharmaceutical had 4 directors:
- Subhra Das - Director
- Aftabuddin Shaikhmahammad Sircar - Director
- Amitabha Chaudhuri - Director
- Chandan Singha Roy - Director
The CIN (Corporate Identification Number) of Atcas Pharmaceutical is U74999WB2016PTC218310. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Atcas Pharmaceutical is at Shantinikatan Apartment Gr. Floor Phase I Block C, Kolkata, West Bengal, India – 700135.
Atcas Pharmaceutical was incorporated on 16 November 2016. It is registered with the Registrar of Companies, Kolkata.
The latest financial statements of Atcas Pharmaceutical on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Atcas Pharmaceutical is 19AAPCA2879R1ZI, registered in West Bengal.
Atcas Pharmaceutical operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.
Tanmoy Kumar Das ceased to be Director on 07 Sep 2018. Aftabuddin Shaikhmahammad Sircar was appointed as Director on 16 Nov 2016. Amitabha Chaudhuri was appointed as Director on 16 Nov 2016. Atcas Pharmaceutical has 5 board changes on record in total.

